Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pro-thyrotropin-releasing hormone processing by recombinant PC1

E A Nillni1, T C Friedman, R B Todd

  • 1Department of Medicine, Brown University, Rhode Island Hospital, Providence 02903, USA.

Journal of Neurochemistry
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On Bronchitis.

The North-Western medical and surgical journal·2023
Same author

Novel biomarker <i>SYT12</i> may contribute to predicting papillary thyroid cancer outcomes.

Future science OA·2017
Same author

A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.

Molecular psychiatry·2017
Same author

A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer's disease patient leads to dementia and depression in mice.

Translational psychiatry·2016
Same author

The Chromogranin A-derived sympathomimetic serpinin depresses myocardial performance in teleost and amphibian hearts.

General and comparative endocrinology·2016
Same author

Carboxypeptidase E (CPE) inhibits the secretion and activity of Wnt3a.

Oncogene·2016

Recombinant PC1 enzyme processes pro-thyrotropin-releasing hormone (proTRH) into smaller peptides. This study identifies PC1 as a key enzyme in proTRH processing, revealing its role in generating TRH progenitor sequences.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Pro-thyrotropin-releasing hormone (proTRH) is the precursor for thyrotropin-releasing hormone (TRH), a key regulator of thyroid-stimulating hormone release.
  • The specific endopeptidase(s) responsible for physiological proTRH conversion remain unidentified.
  • Posttranslational processing of proTRH yields multiple peptide fragments, including five TRH progenitor sequences.

Purpose of the Study:

  • To investigate the in vitro processing of proTRH by recombinant PC1.
  • To identify the specific cleavage sites and resulting peptide intermediates during proTRH processing by PC1.
  • To determine the optimal conditions and cofactor requirements for PC1-mediated proTRH cleavage.

Main Methods:

  • In vitro processing assays using [3H]leucine-labeled or unlabeled proTRH with partially purified recombinant PC1.

Related Experiment Videos

  • Analysis of cleavage products using antibodies against proTRH.
  • Determination of optimal pH and the effect of metal ions (ZnCl2, Ca2+) and chelators (EDTA, EGTA) on enzyme activity.

    • Main Results:

    • Recombinant PC1 cleaved proTRH at positions 153 or 159, generating N-terminal (15-kDa) and C-terminal (10-kDa) intermediates.
    • Further processing of the 15-kDa intermediate yielded 6-kDa and 3.8-kDa peptides, while the 10-kDa intermediate was processed to a 5.4-kDa peptide.
    • Optimal cleavage occurred at pH 5.5, and ZnCl2, EDTA, EGTA, and Ca2+ omission inhibited the formation of specific products.

    Conclusions:

    • Recombinant PC1 enzyme effectively processes proTRH into predicted peptide intermediates.
    • This study provides the first evidence of PC1's role in proTRH processing.
    • PC1 is a likely candidate for the endopeptidase responsible for physiological proTRH conversion.